-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Organogenesis Holdings, Lowers Price Target to $8

Benzinga·02/27/2026 10:35:10
Listen to the news
BTIG analyst Ryan Zimmerman maintains Organogenesis Holdings (NASDAQ:ORGO) with a Buy and lowers the price target from $9 to $8.